168 related articles for article (PubMed ID: 33734614)
1. Disparate outcomes in nonsmall cell lung cancer by immigration status.
Chau B; Ituarte PH; Shinde A; Li R; Vazquez J; Glaser S; Massarelli E; Salgia R; Erhunmwunsee L; Ashing K; Amini A
Cancer Med; 2021 Apr; 10(8):2660-2667. PubMed ID: 33734614
[TBL] [Abstract][Full Text] [Related]
2. How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in California? Explaining the Hispanic paradox.
Patel MI; Schupp CW; Gomez SL; Chang ET; Wakelee HA
J Clin Oncol; 2013 Oct; 31(28):3572-8. PubMed ID: 23960183
[TBL] [Abstract][Full Text] [Related]
3. The Care and Outcomes of Older Persons with Lung Cancer in England and the United States, 2008-2012.
Andreano A; Peake MD; Janes SM; Valsecchi MG; Pritchard-Jones K; Hoag JR; Gross CP
J Thorac Oncol; 2018 Jul; 13(7):904-914. PubMed ID: 29727739
[TBL] [Abstract][Full Text] [Related]
4. Association between race and survival of patients with non--small-cell lung cancer in the United States veterans affairs population.
Ganti AK; Subbiah SP; Kessinger A; Gonsalves WI; Silberstein PT; Loberiza FR
Clin Lung Cancer; 2014 Mar; 15(2):152-8. PubMed ID: 24361249
[TBL] [Abstract][Full Text] [Related]
5. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
6. External Validation of a Survival Nomogram for Non-Small Cell Lung Cancer Using the National Cancer Database.
Young KA; Efiong E; Dove JT; Blansfield JA; Hunsinger MA; Wild JL; Shabahang MM; Facktor MA
Ann Surg Oncol; 2017 Jun; 24(6):1459-1464. PubMed ID: 28168388
[TBL] [Abstract][Full Text] [Related]
7. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
Zaki M; Dominello M; Dyson G; Gadgeel S; Wozniak A; Miller S; Paximadis P
Clin Lung Cancer; 2017 Jan; 18(1):e21-e26. PubMed ID: 27567356
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
[TBL] [Abstract][Full Text] [Related]
10. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases.
Kawaguchi T; Matsumura A; Fukai S; Tamura A; Saito R; Zell JA; Maruyama Y; Ziogas A; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 Jul; 5(7):1001-10. PubMed ID: 20526205
[TBL] [Abstract][Full Text] [Related]
11. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
12. Factors Associated With Survival in Complete Pathologic Response Non-Small Cell Lung Cancer.
Martinez-Meehan D; Lutfi W; Dhupar R; Christie N; Baker N; Schuchert M; Luketich JD; Okusanya OT
Clin Lung Cancer; 2020 Jul; 21(4):349-356. PubMed ID: 32299769
[TBL] [Abstract][Full Text] [Related]
13. Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older.
Driessen E; Detillon D; Bootsma G; De Ruysscher D; Veen E; Aarts M; Janssen-Heijnen M
J Geriatr Oncol; 2019 Jul; 10(4):547-554. PubMed ID: 30876833
[TBL] [Abstract][Full Text] [Related]
14. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
[TBL] [Abstract][Full Text] [Related]
15. Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010-2016 in Sweden: A nationwide observational study.
Bergqvist M; Christensen HN; Wiklund F; Bergström S
Int J Cancer; 2020 May; 146(9):2510-2517. PubMed ID: 31350754
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population.
Kim HC; Ji W; Lee JC; Kim HR; Song SY; Choi CM; ;
Cancer Res Treat; 2021 Oct; 53(4):1033-1041. PubMed ID: 33592139
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Cancer; 2007 Oct; 110(7):1532-41. PubMed ID: 17702091
[TBL] [Abstract][Full Text] [Related]
18. Korean ethnicity as compared with white ethnicity is an independent favorable prognostic factor for overall survival in non-small cell lung cancer before and after the oral epidermal growth factor receptor tyrosine kinase inhibitor era.
Ahn MJ; Lee J; Park YH; Ahn JS; Ziogas A; Zell JA; Park K; Ou SH
J Thorac Oncol; 2010 Aug; 5(8):1185-96. PubMed ID: 20592628
[TBL] [Abstract][Full Text] [Related]
19. Treatment patterns and overall survival among patients with unresectable, stage III non-small-cell lung cancer.
Bobbili P; Ryan K; Duh MS; Dua A; Fernandes AW; Pavilack M; Gomez JE
Future Oncol; 2019 Oct; 15(29):3381-3393. PubMed ID: 31544510
[No Abstract] [Full Text] [Related]
20. Survival disparities following surgery among patients with different histological types of non-small cell lung cancer.
Grosu HB; Manzanera A; Shivakumar S; Sun S; Noguras Gonzalez G; Ost DE
Lung Cancer; 2020 Feb; 140():55-58. PubMed ID: 31865279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
